Investors

2025 First quarter results announcement

We announced our first quarter 2025 results on April 30.

Quarterly results
Q1 2025 Emma Walmsley
Close Video

Behind the science US edition

DNA And Tech Science Image

The role of biomarkers and genetics in ovarian cancer: Five facts

Every five minutes, someone's life changes with a gynecological cancer diagnosis.

red blood cells

Gaining a deeper understanding of myelofibrosis

Myelofibrosis is a rare blood cancer affecting 25,000 in the U.S., causing bone marrow scarring.

Ben and his wife

Meet Ben: From Drug Discovery to Leading Innovation in Boston

Ben Schwartz, VP of Oncology, shares his 20-year GSK journey, from drug discovery to leading research.

Addressing Long-Standing Barriers to Adult Immunization

Our COiMMUNITY Initiative fosters a systematic, collaborative, and approach to boost vaccinations.

Nicole is a scientist in a lab coat working in the lab

Women in science: Nicole Godfrey

As a kid I always enjoyed the simple logic of science and that I could use it to explain the world around me.

Amruta in the office.

Amruta Joshi-Pangu: A mother with a purpose in science

Growing up, I loved science and all the prospects that it offered.

Investors

We announced our quarter 1 2024 results on Wednesday, May 1st.

Visit our global website for latest results

Press releases

View all press releases
Two employees discussing work in the office
Two scientists discussing work in a lab

Choose your path

By bringing outstanding people together in an inclusive environment to do work that matters, we can impact the world’s health.

Careers in the US

GSK Global links

Visit our Global site for additional features

Continue to Company